dr. bekaii-saab on the importance of the redos study in mcrc
Published 6 years ago • 59 plays • Length 0:57Download video MP4
Download video MP3
Similar videos
-
2:27
dr. bekaii-saab on the redos study in metastatic colorectal cancer
-
2:35
dr. bekaii-saab reflects on the findings of the redos trial in mcrc
-
1:42
dr. bekaii-saab discusses the redos study in metastatic crc
-
1:20
dr. bekaii-saab on the use of regorafenib in patients with mcrc
-
1:21
dr. bekaii-saab discusses regorafenib use in mcrc
-
29:36
restore your microbiome with dr nirala jacobi
-
9:40
bifidobacteria | role in gut health weight loss
-
18:44
coronavirus and the microbiome
-
1:16
dr. bekaii-saab on tas-102 and regorafenib in mcrc
-
1:33
dr. bekaii saab on the expansion of treatment options in colorectal cancer
-
0:20
copy of dr. bekaii-saab on tas-102 and regorafenib in mcrc
-
1:39
dr. bekaii-saab on dosing strategies with regorafenib in crc
-
1:56
dr. tanios bekaii-saab on sequencing questions in mcrc
-
0:56
dr. bekaii-saab on tolerability of encorafenib, binimetinib, and cetuximab in braf crc
-
1:07
what are the treatment options for colorectal cancer? - dr. tanios bekaii-saab
-
1:20
tanios bekaii-saab, md: clinical data supporting regorafenib in mcrc
-
2:22
dr. tanios bekaii-saab on new agents to treat colorectal cancer
-
2:26
dr. bekaii-saab on the impact of regorafenib in crc
-
1:12
tanios bekaii-saab, md: mechanisms of action in regorafenib
-
1:27
tanios bekaii-saab, md, comments on dosing regorafenib (stivarga) in 3rd line treatment of mcrc
-
0:57
dr. bekaii-saab discusses the next steps with regorafenib in crc
-
8:18
the optimal dosing strategy for regorafenib in mcrc